{"id":2648,"date":"2017-08-23T09:15:23","date_gmt":"2017-08-23T09:15:23","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=25927"},"modified":"2017-08-23T09:15:23","modified_gmt":"2017-08-23T09:15:23","slug":"medical-marijuana-inc-subsidiary-hempmeds-brasils-sold-doctor-symposium-medical-cannabis-garners-vast-media-coverage-across-brazil","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/08\/23\/medical-marijuana-inc-subsidiary-hempmeds-brasils-sold-doctor-symposium-medical-cannabis-garners-vast-media-coverage-across-brazil\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil"},"content":{"rendered":"
SAN DIEGO,\u00a0Aug. 23, 2017 \u00a0—\u00a0Medical Marijuana, Inc.\u00a0(MJNA), the first publicly traded cannabis company in\u00a0the United States, today announced that its subsidiary\u00a0HempMeds\u00ae Brasil<\/a>\u00a0held a successful, sold-out Doctor Symposium in\u00a0Sao Paulo, Brazil\u00a0on\u00a0August 15, with 50 doctors in attendance, which garnered vast media coverage across\u00a0Brazil.<\/p>\n